Cargando…
Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053169/ https://www.ncbi.nlm.nih.gov/pubmed/30038524 http://dx.doi.org/10.2147/DHPS.S175655 |
| _version_ | 1783340770739093504 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6053169 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60531692018-07-23 Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum] Drug Healthc Patient Saf Corrigendum Dove Medical Press 2018-07-16 /pmc/articles/PMC6053169/ /pubmed/30038524 http://dx.doi.org/10.2147/DHPS.S175655 Text en © 2018 Muto et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
| spellingShingle | Corrigendum Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum] |
| title | Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum] |
| title_full | Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum] |
| title_fullStr | Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum] |
| title_full_unstemmed | Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum] |
| title_short | Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum] |
| title_sort | long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: tempo extension japan trial [corrigendum] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053169/ https://www.ncbi.nlm.nih.gov/pubmed/30038524 http://dx.doi.org/10.2147/DHPS.S175655 |